Findings

What do systematic reviews say?

4 questions · 5 findings · 2 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 20%Low 2 · 40%Moderate 2 · 40%High 0 · 0%

Adalimumab · people with chronic plaque psoriasis

Any systemic treatment showed no clear difference in adalimumab compared with placebo (moderate certainty).

2 findings from 1 review

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis 2020 · Cochrane Headline outcomes only
RR 0.98 [0.65, 1.49]
10 studies · 3485 participants
Moderate
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis 2020 · Cochrane Headline outcomes only
RR 17.82 [14.62, 21.72]
9 studies · 3421 participants
Moderate

Adalimumab (1 RCT; 16 participants) · surgically induced remission in Crohn's disease

It is very uncertain whether the intervention changes adalimumab (1 RCT; 16 participants) (very low certainty).

1 finding from 1 review

Adalimumab (3 RCTs; 37 participants) · surgically induced remission in Crohn's disease

The intervention may leads to lower adalimumab (3 RCTs; 37 participants) (low certainty).

1 finding from 1 review

Adalimumab (2 RCTs; 26 participants) · surgically induced remission in Crohn's disease

The intervention may leads to lower adalimumab (2 RCTs; 26 participants) (low certainty).

1 finding from 1 review